Tejnaksh Healthcare Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Tejnaksh Healthcare Ltd is ₹ 12.83 as of 30 Oct 15:30 . The P/E Ratio of Tejnaksh Healthcare Ltd changed from 36 on March 2021 to 19.9 on March 2026 . This represents a CAGR of -9.41% over 6 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Tejnaksh Healthcare Ltd changed from ₹ 73.94 crore on March 2021 to ₹ 24.23 crore on March 2026 . This represents a CAGR of -16.97% over 6 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Tejnaksh Healthcare Ltd for the Jun '26 is ₹ 2.75 crore as compare to the Mar '26 revenue of ₹ 2.69 crore. This represent the growth of 2.23% The revenue of Vimta Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Tejnaksh Healthcare Ltd for the Jun '26 is ₹ 0.79 crore as compare to the Mar '26 ebitda of ₹ 0.85 crore. This represent the decline of -7.06% The ebitda of Vimta Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Tejnaksh Healthcare Ltd changed from ₹ 0.6 crore to ₹ 0.26 crore over 9 quarters. This represents a CAGR of -31.04% The net profit of Vimta Labs Ltd changed from ₹ 12.28 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Tejnaksh Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Tejnaksh Healthcare Ltd

Tejnaksh Healthcare Limited was incorporated in Mumbai on 18 February, 2008 as a Private Limited Company and converted into Public Limited Company with effect from 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.
Tejnaksh runs an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra.
It provides a complete range of services from consultations and investigations to treatment for Urology.
The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Tejnaksh Healthcare Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Tejnaksh Healthcare Ltd or Vimta Labs Ltd?

Market cap of Tejnaksh Healthcare Ltd is 26 Cr while Market cap of Vimta Labs Ltd is 2,167 Cr

What are the key factors driving the stock performance of Tejnaksh Healthcare Ltd and Vimta Labs Ltd?

The stock performance of Tejnaksh Healthcare Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tejnaksh Healthcare Ltd and Vimta Labs Ltd?

As of October 31, 2026, the Tejnaksh Healthcare Ltd stock price is INR ₹12.83. On the other hand, Vimta Labs Ltd stock price is INR ₹484.85.

How do dividend payouts of Tejnaksh Healthcare Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Tejnaksh Healthcare Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.